Arete Wealth Advisors’s Fortress Biotech FBIO Stock Holding History

Arete Wealth Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,503	Closed	-$15.3K	–	754
2023 Q3	$15.3K	Hold	3,503	–	–	﹤0.01%	492
2023 Q2	$29K	Hold	3,503	–	–	﹤0.01%	652
2023 Q1	$24K	Buy	+3,503	New	+$41.7K	﹤0.01%	634
2022 Q4	–	Sell	-3,503	Closed	-$26K	–	656
2022 Q3	$26K	Buy	+3,503	New	+$52.5K	﹤0.01%	567
2022 Q1	–	Sell	-4,110	Closed	-$102K	–	523
2021 Q4	$102K	Buy	4,110 +3,377	+461%	+$151K	0.01%	489
2021 Q3	$35K	Hold	733	–	–	﹤0.01%	411
2021 Q2	$0	Buy	+733	New	+$44.2K	﹤0.01%	395

Other funds holding FBIO

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

ACM

Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Arete Wealth Advisors's FBIO Position: Q4 2023 in Review

Arete Wealth Advisors sold out of Fortress Biotech (FBIO) in Q4 2023, closing a stake of 3,503 shares — an estimated $15.3K sold.

Arete Wealth Advisors first reported a position in FBIO in Q2 2021 and held it in 7 quarters. The position peaked at $102K in Q4 2021. 42 funds tracked by Wall St. Rank hold FBIO as of Q4 2023.

Arete Wealth Advisors reported no remaining Fortress Biotech position as of Q4 2023 after selling out during the quarter.
Arete Wealth Advisors sold 3,503 Fortress Biotech shares in Q4 2023, an estimated $15.3K.
Arete Wealth Advisors first reported a position in Fortress Biotech in Q2 2021 and held it in 7 quarters.
Arete Wealth Advisors's Fortress Biotech position peaked at $102K in Q4 2021.
42 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2023.

Based on Arete Wealth Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.